---
date created: 2024-11-18
tags:
  - meds
---
**Class:**
- Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

**Mechanism of Action (MOA):**
- Inhibits VMAT2, decreasing the uptake of monoamines into synaptic vesicles and reducing dopamine activity.

**Indications/Uses:**
- Chorea associated with Huntingtonâ€™s disease
- Tardive dyskinesia

**Side Effects:**
- Drowsiness
- Fatigue
- Diarrhea
- Dry mouth
- Insomnia

**Adverse Effects:**
- Depression
- Suicidal thoughts
- QT prolongation

**Nursing Teaching and Implications:**
- Monitor for changes in mood or behavior.
- Educate about potential sedation effects; caution when driving or operating machinery.
- Encourage reporting of any mood changes or suicidal thoughts.

**Contraindications:**
- Suicidal or untreated/inadequately treated depression
- Hepatic impairment
- Known hypersensitivity to deutetrabenazine